Utility of immunology, microbiology, and helminth investigations in clinical assessment of severe asthma

References

• Simpson AJ, Hekking P-P, Shaw DE, Fleming LJ, Roberts G, Riley JH, Bates S, Sousa AR, Bansal AT, Pandis I, et al.; U-BIOPRED Study Group. Treatable traits in the European U-BIOPRED adult asthma cohorts. Allergy 2019;74(2):406–411. doi:https://doi.org/10.1111/all.13629.
   PubMed Web of Science ®Google Scholar
• McDonald VM, Fingleton J, Agusti A, Hiles SA, Clark VL, Holland AE, Marks GB, Bardin PP, Beasley R, Pavord ID, et al. Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report. Eur Respir J 2019;53(5):1802058. doi:https://doi.org/10.1183/13993003.02058-2018.
   PubMed Web of Science ®Google Scholar
• Robinson DS, Campbell DA, Durham SR, Pfeffer J, Barnes PJ, Chung KF; Asthma and Allergy Research Group of the National Heart and Lung Institute. Systematic assessment of difficult-to-treat asthma. Eur Respir J 2003;22(3):478–483. doi:https://doi.org/10.1183/09031936.03.00017003.
   PubMed Web of Science ®Google Scholar
• Clark VL, Gibson PG, Genn G, Hiles SA, Pavord ID, McDonald VM. Multidimensional assessment of severe asthma: a systematic review and meta-analysis. Respirology 2017;22(7):1262–1275. doi:https://doi.org/10.1111/resp.13134.
   PubMed Web of Science ®Google Scholar
• Hew M, Menzies-Gow A, Hull JH, Fleming L, Porsbjerg C, Brinke AT, Allen D, Gore R, Tay TR. Systematic assessment of difficult-to-treat asthma: principles and perspectives. J Allergy Clin Immunol Pract 2020;8(7):2222–2233. doi:https://doi.org/10.1016/j.jaip.2020.02.036.
   PubMed Web of Science ®Google Scholar
• Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, Adcock IM, Bateman ED, Bel EH, Bleecker ER, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 2014;43(2):343–373. doi:https://doi.org/10.1183/09031936.00202013.
   PubMed Web of Science ®Google Scholar
• Jeimy S, Tsoulis MW, Hachey J, Kim H. Eligibility of monoclonal antibody-based therapy for patients with severe asthma: a Canadian cross-sectional perspective. Allergy Asthma Clin Immunol 2018;14:68. doi:https://doi.org/10.1186/s13223-018-0301-6.
   PubMed Web of Science ®Google Scholar
• Contoli M, Ito K, Padovani A, Poletti D, Marku B, Edwards MR, Stanciu LA, Gnesini G, Pastore A, Spanevello A, et al. Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells. Allergy 2015;70(8):910–920. doi:https://doi.org/10.1111/all.12627.
   PubMed Web of Science ®Google Scholar
• Juhn YJ. Risks for infection in patients with asthma (or other atopic conditions): is asthma more than a chronic airway disease? J Allergy Clin Immunol 2014;134(2):247–257. quiz 58–59. doi:https://doi.org/10.1016/j.jaci.2014.04.024.
   PubMed Web of Science ®Google Scholar
• Nicholas B, Dudley S, Tariq K, Howarth P, Lunn K, Pink S, Sterk PJ, Adcock IM, Monk P, Djukanović R, et al.; U-BIOPRED study group. Susceptibility to influenza virus infection of bronchial biopsies in asthma. J Allergy Clin Immunol 2017;140(1):309–312 e4. doi:https://doi.org/10.1016/j.jaci.2016.12.964.
   PubMed Web of Science ®Google Scholar
• Contoli M, Pauletti A, Rossi MR, Spanevello A, Casolari P, Marcellini A, Forini G, Gnesini G, Marku B, Barnes N, et al. Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD. Eur Respir J 2017;50(4):1700451. doi:https://doi.org/10.1183/13993003.00451-2017.
   PubMed Web of Science ®Google Scholar
• Youssef J, Novosad SA, Winthrop KL. Infection risk and safety of corticosteroid use. Rheum Dis Clin North Am 2016;42(1):157–176. ix–x. doi:https://doi.org/10.1016/j.rdc.2015.08.004.
   PubMed Web of Science ®Google Scholar
• Padilla-Galo A, Olveira C, Fernández de Rota-Garcia L, Marco-Galve I, Plata AJ, Alvarez A, Rivas-Ruiz F, Carmona-Olveira A, Cebrian-Gallardo JJ, Martinez-Garcia MA, et al. Factors associated with bronchiectasis in patients with uncontrolled asthma; the NOPES score: a study in 398 patients. Respir Res 2018;19(1):43. doi:https://doi.org/10.1186/s12931-018-0746-7.
   PubMed Web of Science ®Google Scholar
• Akaba T, Kondo M, Toriyama M, Kubo A, Hara K, Yamada T, Yoshinaga K, Tamaoki J. Common variable immunodeficiency diagnosed during the treatment of bronchial asthma: unusual cause of wheezing. Respir Med Case Rep 2015;16:41–44. doi:https://doi.org/10.1016/j.rmcr.2015.07.002.
   PubMedGoogle Scholar
• Milota T, Bloomfield M, Parackova Z, Sediva A, Bartunkova J, Horvath R. Bronchial asthma and bronchial hyperresponsiveness and their characteristics in patients with common variable immunodeficiency. Int Arch Allergy Immunol 2019;178(2):192–200. doi:https://doi.org/10.1159/000494128.
   PubMed Web of Science ®Google Scholar
• Taylor SL, Leong LEX, Choo JM, Wesselingh S, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Jenkins C, et al. Inflammatory phenotypes in patients with severe asthma are associated with distinct airway microbiology. J Allergy Clin Immunol 2018;141(1):94–103. doi:https://doi.org/10.1016/j.jaci.2017.03.044.
   PubMed Web of Science ®Google Scholar
• Schär F, Trostdorf U, Giardina F, Khieu V, Muth S, Marti H, Vounatsou P, Odermatt P. Strongyloides stercoralis: global distribution and risk factors. PLoS Negl Trop Dis 2013;7(7):e2288. doi:https://doi.org/10.1371/journal.pntd.0002288.
   PubMed Web of Science ®Google Scholar
• Lloyd CM, Snelgrove RJ. Type 2 immunity: expanding our view. Sci Immunol 2018;3(25):eaat1604. doi:https://doi.org/10.1126/sciimmunol.aat1604.
   Web of Science ®Google Scholar
• Buonfrate D, Requena-Mendez A, Angheben A, Muñoz J, Gobbi F, Van Den Ende J, Bisoffi Z. Severe strongyloidiasis: a systematic review of case reports. BMC Infect Dis 2013;13:78. doi:https://doi.org/10.1186/1471-2334-13-78.
   PubMed Web of Science ®Google Scholar
• Baker EC, Ming DK, Choudhury Y, Rahman S, Smith PJ, Muñoz J, Chiodini PL, Griffiths CJ, Whitty CJM, Brown M. High prevalence of Strongyloides among south Asian migrants in primary care – associations with eosinophilia and gastrointestinal symptoms. Pathogens 2020;9(2):103. doi:https://doi.org/10.3390/pathogens9020103.
   Web of Science ®Google Scholar
• Biagini RE, Schlottmann SA, Sammons DL, Smith JP, Snawder JC, Striley CAF, MacKenzie BA, Weissman DN. Method for simultaneous measurement of antibodies to 23 pneumococcal capsular polysaccharides. Clin Diagn Lab Immunol 2003;10(5):744–750. doi:https://doi.org/10.1128/cdli.10.5.744-750.2003.
   PubMedGoogle Scholar
• Browning MJ, Lim MTC, Kenia P, Whittle M, Doffinger R, Barcenas-Morales G, Kumararatne D, Viskaduraki M, O'Callaghan C, Gaillard EA, et al. Pneumococcal polysaccharide vaccine responses are impaired in a subgroup of children with cystic fibrosis. J Cyst Fibros 2014;13(6):632–638. doi:https://doi.org/10.1016/j.jcf.2014.02.002.
   PubMed Web of Science ®Google Scholar
• Balmer P, Cant AJ, Borrow R. Anti-pneumococcal antibody titre measurement: what useful information does it yield? J Clin Pathol 2007;60(4):345–350. doi:https://doi.org/10.1136/jcp.2006.041210.
   PubMed Web of Science ®Google Scholar
• Orange JS, Ballow M, Stiehm ER, Ballas ZK, Chinen J, De La Morena M, Kumararatne D, Harville TO, Hesterberg P, Koleilat M, et al. Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol 2012;130(3 Suppl):S1–S24. doi:https://doi.org/10.1016/j.jaci.2012.07.002.
   PubMed Web of Science ®Google Scholar
• Buonfrate D, Sequi M, Mejia R, Cimino RO, Krolewiecki AJ, Albonico M, Degani M, Tais S, Angheben A, Requena-Mendez A, et al. Accuracy of five serologic tests for the follow up of Strongyloides stercoralis infection. PLoS Negl Trop Dis 2015;9(2):e0003491. doi:https://doi.org/10.1371/journal.pntd.0003491.
   PubMed Web of Science ®Google Scholar
• Hamilos DL, Young RM, Peter JB, Agopian MS, Iklé DN, Barka N. Hypogammaglobulinemia in asthmatic patients. Ann Allergy 1992;68(6):472–481.
   PubMedGoogle Scholar
• Dupin C, Marchand-Adam S, Favelle O, Costes R, Gatault P, Diot P, Grammatico-Guillon L, Guilleminault L. Asthma and hypogammaglobulinemia: an asthma phenotype with low type 2 inflammation. J Clin Immunol 2016;36(8):810–817. doi:https://doi.org/10.1007/s10875-016-0335-9.
   PubMed Web of Science ®Google Scholar
• Kawano T, Matsuse H, Obase Y, Kondo Y, Machida I, Tomari S, Mitsuta K, Fukushima C, Shimoda T, Kohno S, et al. Hypogammaglobulinemia in steroid-dependent asthmatics correlates with the daily dose of oral prednisolone. Int Arch Allergy Immunol 2002;128(3):240–243. doi:https://doi.org/10.1159/000064258.
   PubMed Web of Science ®Google Scholar
• Kishiyama JL, Valacer D, Cunningham-Rundles C, Sperber K, Richmond GW, Abramson S, Glovsky M, Stiehm R, Stocks J, Rosenberg L, et al. A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma. Clin Immunol 1999;91(2):126–133. doi:https://doi.org/10.1006/clim.1999.4714.
   PubMed Web of Science ®Google Scholar
• Salmun LM, Barlan I, Wolf HM, Eibl M, Twarog FJ, Geha RS, Schneider LC. Effect of intravenous immunoglobulin on steroid consumption in patients with severe asthma: a double-blind, placebo-controlled, randomized trial. J Allergy Clin Immunol 1999;103(5 Part 1):810–815. doi:https://doi.org/10.1016/S0091-6749(99)70424-0.
   PubMed Web of Science ®Google Scholar
• Esquivel A, Busse WW, Calatroni A, Togias AG, Grindle KG, Bochkov YA, Gruchalla RS, Kattan M, Kercsmar CM, Khurana Hershey G, et al. Effects of omalizumab on rhinovirus infections, illnesses, and exacerbations of asthma. Am J Respir Crit Care Med 2017;196(8):985–992. doi:https://doi.org/10.1164/rccm.201701-0120OC.
   PubMed Web of Science ®Google Scholar
• Klion AD, Nutman TB. The role of eosinophils in host defense against helminth parasites. J Allergy Clin Immunol 2004;113(1):30–37. doi:https://doi.org/10.1016/j.jaci.2003.10.050.
   PubMed Web of Science ®Google Scholar
• Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun MM. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001;345(15):1098–1104. doi:https://doi.org/10.1056/NEJMoa011110.
   PubMed Web of Science ®Google Scholar
• Woolnough KF, Richardson M, Newby C, Craner M, Bourne M, Monteiro W, Siddiqui S, Bradding P, Pashley CH, Wardlaw AJ, et al. The relationship between biomarkers of fungal allergy and lung damage in asthma. Clin Exp Allergy 2017;47(1):48–56. doi:https://doi.org/10.1111/cea.12848.
   PubMed Web of Science ®Google Scholar
• Pfeffer PE, Corrigan CJ. An imbalance between proteases and endogenous protease inhibitors in eosinophilic airway disease. Am J Respir Crit Care Med 2017;195(6):707–708. doi:https://doi.org/10.1164/rccm.201610-2020ED.
   PubMed Web of Science ®Google Scholar
• Kurt E, Yildirim H, Kiraz N, Orman A, Metintas M, Akgun Y, Erginel S. Oropharyngeal candidiasis with dry-powdered fluticasone propionate: 500 microg/day versus 200 microg/day. Allergol Immunopathol (Madr) 2008;36(1):17–20. doi:https://doi.org/10.1157/13115666.
   PubMed Web of Science ®Google Scholar
• Ramachandran S, Shah A, Pant K, Bhagat R, Jaggi OP. Allergic bronchopulmonary aspergillosis and Candida albicans colonization of the respiratory tract in corticosteroid-dependent asthma. Asian Pac J Allergy Immunol 1990;8(2):123–126.
   PubMed Web of Science ®Google Scholar
• Naglik JR, Konig A, Hube B, Gaffen SL. Candida albicans–epithelial interactions and induction of mucosal innate immunity. Curr Opin Microbiol 2017;40:104–112. doi:https://doi.org/10.1016/j.mib.2017.10.030.
   PubMed Web of Science ®Google Scholar
• Mori A, Ikeda Y, Taniguchi M, Aoyama C, Maeda Y, Hasegawa M, Kobayashi N, Akiyama K. IL-5 production by peripheral blood Th cells of adult asthma patients in response to Candida albicans allergen. Int Arch Allergy Immunol 2001;125 (Suppl 1):48–50. doi:https://doi.org/10.1159/000053853.
   PubMedGoogle Scholar
• Fukutomi Y, Taniguchi M. Sensitization to fungal allergens: resolved and unresolved issues. Allergol Int 2015;64(4):321–331. doi:https://doi.org/10.1016/j.alit.2015.05.007.
   PubMed Web of Science ®Google Scholar
• Wakayama N, Matsune S, Okubo K. Delayed type of allergic skin reaction to Candida albicans in eosinophilic rhinosinusitis cases. Auris Nasus Larynx 2018;45(1):111–115. doi:https://doi.org/10.1016/j.anl.2017.05.009.
   PubMed Web of Science ®Google Scholar
• Johnson DC. Chronic candidal bronchitis: a consecutive series. Open Respir Med J 2012;6:145–149. doi:https://doi.org/10.2174/1874306401206010145.
   PubMedGoogle Scholar
• Schreiber J, Broker BM, Ehmann R, Bachert C. Nonatopic severe asthma might still be atopic: sensitization toward Staphylococcus aureus enterotoxins. J Allergy Clin Immunol 2019;143(6):2279–2280 e2. doi:https://doi.org/10.1016/j.jaci.2019.01.018.
   PubMed Web of Science ®Google Scholar